ArticleArthroscopy, sports medicine, and rehabilitation2025
Combined Latissimus Dorsi/Teres Major Transfer and Superior Capsular Reconstruction Using Autogenous Biceps Tendon Effectively Relieves Pain and Improves Shoulder Function for Posterosuperior Irreparable Rotator Cuff Tears.
Article in Arthroscopy, sports medicine, and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Optimizing reverse total shoulder arthroplasty for combined loss of elevation and external rotation: latissimus dorsi and teres major transfer, lateralization, or both?JSES international · 2026Article
- An Arthroscopic Upper Superior Capsule Reconstruction Using a U-Fold Long Head of the Biceps Tendon Autograft for the Treatment of Irreparable Massive Rotator Cuff Tears.Arthroscopy techniques · 2025Article
- Comparison of isolated tenotomy vs. tenotomy with tenodesis for long head of biceps tendon in middle-aged and elderly patients undergoing rotator cuff repair: a retrospective study.Frontiers in surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the clinical outcomes of fully arthroscopic latissimus dorsi (LD) and teres major (TM) transfer combined with superior capsular reconstruction (SCR) using long head of biceps (LHB) tendon in patients with posterior-superior irreparable cuff tears (PSIRCTs). Methods: A retrospective analysis was conducted on patients who underwent fully arthroscopic LDTM transfer with SCR using LHB tendon for PSIRCT between January 2021 and November 2023. The inclusion criteria were failure of conservative treatments, PSIRCTs with intact LHB, no or minimal glenohumeral arthritis, and minimum of one year follow-up. Patients were excluded if loss to follow-up, or follow-up of less than 1 year. Clinical assessments included the visual analog scale for pain, Simple Shoulder Test, Subjective Shoulder Value, and American Shoulder and Elbow Surgeons scores, and range of motion (ROM). Using 0.5 standard deviation distribution-based method, the percentage of the minimal clinically important difference was evaluated. Results: A total of 17 patients were included (10 male and 7 female), with a mean follow-up period of 16.3 ± 5.9 months (range, 12-27 moths). Significant improvements were observed across all outcome measures, including the visual analog scale (6.3 ± 2.0 to 2.0 ± 2.2), Simple Shoulder Test (3.3 ± 2.6 to 7.6 ± 2.9), Subjective Shoulder Value (34.1 ± 16.7 to 71.7 ± 13.8), Activities of Daily Living requiring active External Rotation (18.3 ± 8.3 to 26.2 ± 5.2), and American Shoulder and Elbow Surgeons (37.7 ± 21.8 to 77.3 ± 16.8) scores (all Conclusions: Fully arthroscopic LDTM with SCR using LHB tendon effectively alleviated pain and improved shoulder function in patients with PSIRCTs at short term follow-up. Significant improvements were observed in pain, patient-reported outcome measures, and ROM, with no progression of glenohumeral arthritis and no significant complications reported. Level of Evidence: Level IV, therapeutic case series.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.